Gangliosides have been proposed as modulators of transmembrane signaling. Recently, GM3, a glycosphingolipid containing monosaialic acids, is thought to be one of the key molecules of signal transduction in mammalian cells. In this study, we used mouse embryonic fibroblast cell lines (MEFs) established from sialyltransferase-I knockout mice (GM3 synthase KO mice) to evaluate the regulation of mitogenic signals by gangliosides. Cell proliferation assay revealed a higher growth potential of GM3 KO MEFs. Immunoblots showed upregulation of Ras/Raf/MEK/ERK pathway in GM3 KO MEFs, and these signals resulted in enhanced translocation of ERK into the nuclei. Further, both exogenous and endogenous add-back of GM3 decreased the activities of MAPK in GM3 KO MEFs. In addition, GM3 KO MEFs formed foci in high-density culture condition, and analyses of cell cycle modulators revealed the resistance of GM3 KO MEFs for entering cell cycle arrest. Finally, sustained expressions of c-Fos in GM3 KO MEFs were shown to correlate with DNA-binding activity between c-Fos and AP-1. These results demonstrate that the deletion of sialyltransferase-I changes the character of MEFs to a highly activated state of the MAPK pathway, indicating the critical role of GM3 as a regulator of membranetransmitted signals.
Introduction
Mitogen-activated protein kinase (MAPK) pathway is a primordial signaling system that modulates cell proliferation and differentiation (Zou et al., 1998; Kolch, 2000) . Numerous kinds of signaling molecules and stimuli phosphorylate cell surface receptors and activate MAPK. Although MAPK has been recently identified with six different but structurally resembling molecules, the prototype of that is the Ras/Raf/MEK/ERK. At the final stage of this pathway, activated ERK translocates into the nuclei and alters gene expression by phosphorylation of intra-nucleus substrates or by activation of several transcriptional factors including activator protein-1 (AP-1) (Gum et al., 1997) .
Gangliosides are glycosphingolipids containing one or more saialic acids, and exist in several types of eukaryotic cells (Huwiler et al., 2000) . They are bound in the plasma membrane, and are not only essential structural components of the membrane but also are transducers of signals that participate in cell-surface events, including subcellular targeting, cell adhesion, and the phosphorylation of transmembrane receptors.
Among various gangliosides, GM3, synthesized by sialyltransferase-I, sites at the top of a-series gangliosides and upstream of both b-and c-series of gangliosides. When membrane domain is purified biochemically using nonionic detergent, GM3 presents particularly predominant in detergent-insoluble glycolipid-enriched domain where glycolipids interact with other transducer molecules (Smart et al., 1999) .
There is a variety of evidence suggesting that changes in ganglioside expressions can alter membrane-transmitted signals. GM3 inhibits platelet-derived growth factor (PDGF)-stimulated DNA synthesis by suppressing the receptor dimerization in the glioma cell line (Van Brocklyn et al, 1993) . Proliferation of vascular smooth muscle cells is also inhibited by GM3, whereas GM1 and GM2 have a stimulatory effect (Gouni-Berthold et al., 2001) . GM3 accelerated epidermal growth factor (EGF) receptor dephosphorylation in A431 cell membranes (Hanai et al., 1998) , and GM1 also affected EGF-induced EGF receptor phosphorylation and cell proliferation in human neuroblastoma cells (Scorrano et al., 1999) . Thus, ganglioside is thought to be one of key molecules in signal transduction events of the plasma membrane; however, the details of the roles of gangliosides remain incompletely understood.
To evaluate the contribution of GM3 for the regulation of mitogenic signals, we established primary mouse embryonic fibroblasts (MEFs) cell lines from GM3 synthase knockout mice (Yamashita et al., 2003) . Interestingly, GM3 synthase knockout MEFs (GM3 KO MEFs) showed high-level mitogenic activities in both cell proliferation and foci formation, owing to the activation of Ras/Raf/MEK1/ERK pathway and upregulation of DNA binding between c-Fos/AP-1. Further, we also examined the expressions of the cell cycle modulators and demonstrated that GM3 KO MEFs were resistant to enter cell cycle arrest. Thus, the results presented show that the deletion of GM3 synthase can modulate cellular proliferation, transformation and cell cycle control.
Results

Profiles of GM3 expression in MEFs
Glycolipid accumulations in MEFs were evaluated by thin-layer chromatography analysis ( Figure 1a ). Profiling of gangliosides was dramatically changed between GM3 KO MEFs and WT MEFs in acid gangliosides (left panel) and neutral glycolipid (right panel). In acid gangliosides, GM3 expression was undetectable in KO MEFs, and other faint lanes may correspond to O-series gangliosides, which do not require the activity of GM3 synthase as has been described by Yamashita et al. (2003) . In neutral glycolipid, slight accumulations of either lactosylceramide (LacCer) or paragloboside were detected, supporting the blockade of sialtransferase-I activities. In Figure 1b , immunofluorescence staining showed abundant expressions of GM3 in WT MEFs, whereas it was deleted in GM3 KO MEFs.
Cell proliferation assay
To analyse the effect of the deletion of GM3 on cellular viabilities, we next examined cell proliferation activities of both strains of MEFs by MTT assay, determined 24 h after plating cells (Figure 1c) . The results showed that GM3 KO MEFs obtained significantly higher proliferation activities than that of WT MEFs in every experimental group (*1; Po0.01, *2; Po0.05, *3; Po0.01).
Signal transduction through MAPK Previous reports suggested that GM3 might interfere with MAPK signal transduction in numeral types of mammalian cells (Garofalo et al., 2002; Wang et al., 2003) . Therefore, we considered that loss of GM3 expression would be predicted to induce activation of MAPK pathway and higher migration activities in MEFs.
To estimate MAPK activation, we first analysed the activation of Ras, a major upstream effector of MAPK, by immunoprecipitaion of Ras-GTP. The results showed that both strains of MEFs obtained almost the same amount of total Ras (Ras). However, a substantial increase was shown in the amount of activated Ras of GM3 KO MEFs compared with WT MEFs. Immunoblotting of Raf, a main effector recruited by GTP-bound Ras to activate MAPK pathway, showed abundant expression of phosphorylated (p) Raf in GM3 KO MEFs but not in WT MEFs. Finally, every strain of GM3 KO MEFs showed abundant expression of pERK than WT MEFs, although the expressions of total ERK (ERK) were same ( Figure 2a) .
To further verify the selective action of GM3 deletion on MAPK, we examined the phosphorylation of other two major signaling pathways of MAPK, p38 and JNK. The result showed that GM3 deletion did not modulate expression and phosphorylation of p38 or JNK (Figure 2b ).
Once the signaling cascade is stimulated, activation of Ras leads to the activation of ERK. Activated ERK, in turn, translocates from the cytoplasm to the nucleus to phosphorylate a wide spectrum of transcriptional factors. Figure 2c shows that a large amount of ERK in both GM3 KO and WT MEFs are shifted to the In every experimental group, GM3 KO MEFs showed significant higher growth rate than WT MEFs (*1, *3; Po0.01, *2; Po0.05).
Regulation of MAPK and c-Fos/AP-1 in GM3 KO MEFs A Hashiramoto et al nuclear fraction. In both fractions, GM3 KO MEFs expressed more pERK than that by WT MEFs, and nuclear fraction of ERK were indeed activated.
Add-back assay of GM3 and GM3 synthase To determine whether exogenous treatment of GM3 could alter cellular mitogenic activities through MAPK, we performed the add-back assay of GM3 into both strains of MEFs (Figure 3a) . In GM3 KO MEFs, expressions of pERK were decreased dose-dependently after a 16 h incubation with GM3. The signaling cascade was also followed by pull-down assay of GTP Ras, and GM3 KO MEFs also showed the decreasing of activated Ras by GM3 treatments, suggesting that exogenously added GM3 might change the character of GM3 KO MEFs to resemble WT MEFs. In both blotting of ERK and Ras, WT MEFs appeared to be influenced much by GM3 treatments.
For the supports of these results, we transfected either sense or antisense GM3 synthase into GM-3 KO MEFs ( Figure 3b ) and examined the phosphorylation state of ERK. In every cell lines, antisense-transfected cells showed higher phosphorylarion states than sensetransfected cells, and the ratio of pERK/ERK showed significant differences in both groups by densitometry scanning (Figure 3c ).
Effects of MAPK inhibitor on cell proliferation
The effects of PD98059, a common inhibitor of MAPK, on cell proliferation were examined using GM3 KO and Immunoblots of phosphorylated (p) p38, p38, p JNK and JNK. Phosporylation of both p38 and JNK showed no differences between GM3 KO MEFs and WT MEFs. The result was represented in three independent experiments. (c) Immunoblots of phosphorylated (p) ERK and ERK using cytoplasmic (C) and nuclear (N) fractions of MEFs. Large amounts of ERK were detected in N-fraction in both strains of MEFs owing to nuclear translocation of ERK. In particular, expressions of pERK in GM3 KO MEFs were higher than that in WT MEFs in both C-and N-fractions. The result was represented in three independent experiments.
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A Hashiramoto et al WT MEFs (Figure 4a ). In both KO and WT MEFs, serum starvation decreased cell proliferation. Further, PD98059 showed significant suppression on the proliferation of KO MEFs in a dose-dependent fashion. In Figure 4b , the inhibitory effects of PD98059 were examined further by blotting MEK1, an upstream dual protein kinase of ERK and an direct target of PD98059, and ERK. The expressions of both phosphorylated (p) MEK1 and pERK were well inhibited in a dosedependent manner of PD98059; however, GM3 KO MEFs appeared to be more resistant to PD98059 treatments than WT MEFs.
Effect of GM3-deletion on foci formation and cell cycle modulators As GM3 KO MEFs showed higher activity in cell proliferation, we next assessed whether their mitogenic ability is sufficient to form the focus when cultured in high-density condition with and without PD98059.
As shown in Figure 5a , GM3 KO MEFs formed foci, whereas WT MEFs did not. The spindle form of WT MEFs changed to the round shape when they grew up, however, they have never formed any foci. In addition, inhibition of MAPK by PD98059 decreased the ability of foci formation in GM3 KO MEFs, as expected ( Figure 5b ). The quantification of results showed the significant difference by treatments with 50 mM PD98059 (Po0.05; GM3 KO MEFs in FBS vs GM3 KO MEFs in FBS þ PD), but not with 10 mM PD98059.
The rate of cell growth is reduced when cells are in intimate contact with other cells, that is, a phenomenon called as a contact inhibition (Groth and Willumsen, 2005) . Thus, we used three different markers to study in MEFs before and after confluence. GM3 KO MEFs showed higher expressions of cyclin D1 at 48 h after 100% confluence, although it was completely diminished in WT MEFs. In contrast, WT MEFs expressed higher level of p21 and p27 at 48 h after 100% confluence, whereas GM3 KO MEFs kept lower level of expression in p21 and p27 during the whole experimental period. The result was represented in three independent experiments.
Regulation of MAPK and c-Fos/AP-1 in GM3 KO MEFs A Hashiramoto et al the progression of cell cycle of MEFs before and after confluence (80% confluence, 100% confluence and 48 h after 100% confluence). Cyclin D1 is a marker for the G1/S transition that shows the highest expression in the actively dividing phase of cells, and is absent in the confluence phase (Fu et al., 2004) . In Figure 5b , the expressions of cyclin D1 remained higher in three different time courses in GM3 KO MEFs. However, in WT MEFs, cyclin D1 expressions were abundant until the day of 100% confluence and completely diminished 48 h after 100% confluence. p21 and p27, the other family members of CDK inhibitor, cause G1 arrest by targeting G1 cyclin-CDK complex (Li and Blow, 2001) . During the time course from 80% confluence to 48 h after 100% confluence, GM3 KO MEFs showed lower expression of p21 and p27. In contrast, WT MEFs expressed higher level of p21 at 48 h after 100% confluence. Even more, expression of p27 increased during the three experimental time courses in WT MEFs.
Effects of GM3 deletion on c-Fos/AP-1 Finally, we explored the relation between MAPK and AP-1, a putative downstream target of ERK. AP-1 dimers are composed of Jun family proteins (c-Jun, Jun-B, Jun-D) homodimers or Jun heterodimers with Fos, and the expression of Fra-1, a Fos-related antigen, is significantly dependent on MAPK-induced AP-1 binding (Hoffmann et al., 2005) .
As shown in Figure 6a , expressions of c-Fos and Fra-1 were significantly reduced at 48 h after 100% confluence in WT MEFs owing to contact inhibition, although they did not reduce in GM3 KO MEFs. In contrast, expressions of Jun family proteins did not change in both strains of MEFs. As expected, 50 mM of PD98059 showed sufficient inhibition on the expression of c-Fos and Fra-1 (Figure 6b ). In the same experimental time courses, DNA-binding activity between c-Fos and AP-1 were in higher level at 80% confluence of KO and WT MEFs, slightly decreased at 48 h after 100% confluence in KO MEFs, and strongly inhibited at 48 h after 100% confluence in WT MEFs (Figure 6c ; upper panel). In addition, PD98059 suppressed the DNA-binding activity in KO MEFs dose-dependently, even in the concentration of 10 mM (Figure 6c ; lower panel).
Discussion
The lipid membrane domain, where glycosphingolipids, sphingomyelins and cholesterols cluster together, has been closely implicated in signal transduction. Cell surface gangliosides exist in the glycosphingolipidenriched domain and are believed to modulate transmembrane signals. Recent reports show that clustered glycosphingolipids initiate signal transductions through the interaction of their lipid portion with transducer molecules of cell surface receptors, although gangliosides themselves lack enzymatic features (Li et al., 2001) . Therefore, gangliosides are thought to play a major role for sensing stimuli and transduction of signals by aggregating to growth factor receptors in the membrane domains.
On the other hand, protein tyrosine kinase is another critical component of the signaling pathway that control cell proliferation. Once they are activated by various kinds of stimuli, autophosphorylation of the receptor results in the activation of the MAPK pathway (Cobb and Goldsmith, 1995) . GM3 plays a role in the activation of phosphatase, as shown in studies by using phoshatase inhibitors, antisense RNA or gene transfection (Suarez Pestana et al., 1999) . In the nuclei, MAPK regulates expressions of several genes where AP-1-binding sites are found, then induces DNA synthesis and cell differentiation. The starting point of this process is the activation of GTPase Ras. Ras is activated by binding GTP and associates with serine/threonine kinase Raf. Finally, Raf activates MEK, which in turn 
Regulation of MAPK and c-Fos/AP-1 in GM3 KO MEFs
A Hashiramoto et al activates MAPK. In a report using B16 melanoma cells, exogenously added GM3 was shown to organize signal transduction through plasma membrane by affecting the expression of Ras (Iwabuchi et al., 1998) . Then, what would happen if major components of gangliosides were deleted from plasma membrane? Would signals be enhanced or reduced? To answer these questions, we have established GM3 KO MEFs from GM3 synthase knockout mice. Investigation of these cell lines indicated that the deletion of GM3 synthase alter cell mitogenesis in several parameters.
Our data demonstrate two major points. One is that the deletion of GM3 alters the mechanism of signal transduction through MAPK cascade. Ras is one of the most early phase molecules affected just after the stimuli pass the membrane. In Figure 2a , GM3 KO MEFs showed a higher amount of GST-Ras reflecting a higher susceptibility of GM3 KO MEFs to stimuli. In addition, Figures 2 and 4 showed that Raf, MEK and ERK are constitutively active in GM3 KO MEFs, and that treatment with PD98059 reduced the expression level of pERK and pMEK1 in GM3 KO MEFs to the level of WT MEFs. These observations indicate that the deletion of GM3 synthase enhanced the mitogenic signals based on MAPK. For the further support of this notion, immunoblots using cytoplasmic and nuclear fractions show that a large amount of ERK in GM3 KO MEFs shifted to the nuclei (Figure 2c ) and upregulated cell proliferation, followed by activation of the nuclear transcriptional factors, AP-1 (Figure 6 ). GM3 KO MEFs grew significantly faster than WT MEFs in normal culture conditions (Figure 1c) , and the proliferation was also inhibited by PD98059 in a dosedependent fashion (Figure 4a ). Ras and ERK activities decreased when GM3 KO MEFs were treated with GM3, and vice versa, transfection of antisense GM3 synthase increased ERK activity in GM-3 KO MEFs (Figure 3 ). These results demonstrate a closely related interaction between GM3 expression and MAPK signaling. As reported, c-Fos is a direct substrate of ERK both in vitro and in vivo (Murphy et al., 2002 : Monje et al., 2003 , and Fra-1 expression is controlled by ERK (Hoffmann et al., 2005) . Presumably, activation of Ras/c-Raf/MEK1/ERK pathway in GM3 KO MEFs resulted in upregulation of c-Fos and Fra-1 (Figure 6 ).
The other major point is the resistance of GM3 KO MEFs to enter cell cycle arrest. As the potential of cell growth of GM3 KO MEFs was so high, even when they reached to the confluence state, they proceeded to form foci. This suggests that deletion of GM3 leads to density-independent cell growth. In general, the regulation of the cell cycle by mitogen is restricted to the G1 phase, and G1 progression depends on the expression of D-type cyclins. Especially, the accumulation of cyclin D1 results in the cyclin D-cdk4/6 complex formation, leading to a redistribution of p21 and p27 (Danen and Yamada, 2001 ). In addition, Nakatsuji and Miller (2001) have reported that GM3 showed no cytotoxic effects on the fibroblast, however, decreased expression of p27 was detected. In our study, WT MEFs showed the typical expression pattern of cyclin D1, p21 and p27 during their process of confluency, although GM3 KO MEFs did not show any features of cell cycle arrest (Figure 5c ).
The autophosphorylation of receptors recruits multiple signaling molecules, including phospholipase C-g (PLC-g), Ras GPT and phosphatidylinositol-3 0 kinase (PI3K) into the membrane-associated complex (Cullen, 2001; Radeff-Huang et al., 2004) . The activation of their downstream molecules elicits activation of protein kinase, one of which is MAPK. It is also proposed that cellular responses to growth factor stimuli are dependent not only on the activation of growth factor receptors by specific growth factors but also on synchronous signals that elevate intracellular signals like cAMP, which activate MAPK in the same cells (Ballif and Blenis, 2001) . Indeed, when we compare the blotting of pERK and pMEK1 shown in Figure 4b , the ratio of inhibitory effect of PD98059 was much higher in pMEK. This is mainly because PD98059 affects directly the expression of MEK1. We should also consider the possibility that the activation of MAPK in GM3 KO MEFs does not entirely depend on the stream of Ras/Raf/MEK1, but partly on other sources of mitogen including PLC-g, PI3K or cAMP. On the other hand, growth stimuli, activation of tyrosine kinase and Ras upregulate cyclin D1 and result in cell proliferation through MAPK activation, simultaneously inducing p21 activity and blocking further proliferation (Blagosklonny, 1999) . p21À/À MEFs are reported to be deficient in their ability to arrest in G1 and to show significant growth alternation (Deng et al., 1995) . Loss of contact inhibition as seen in GM3 KO MEFs is a common phenotype of oncogenic cells. Reports that GM3 treatment on primary human high-grade glioma showed toxic effects of GM3 on tumor development (Noll et al., 2001 ) are supportive to our observation.
Glycosphingolipids exist as clusters and form the glycosphingolipid-enriched microdomain on the plasma membrane where various modulation of signal transduction occurs (van Meer and Holthuis, 2000) . The mechanism for the inhibition of mitogenic activities by GM3, when stimuli activate EGF receptors, is the decrease in the number of EGF receptors that are available for sensing or binding to ligands (Wang et al., 2001) . Hakomori et al. (1998) reported that over 90% of GM3 present in the glycosphingolipid-enriched microdomain and GM3 was co-precipitated with transducer molecules, such as c-src, H-ras or Rho in B16 cells. Indeed, exogenously added GM3 was thought to accumulate in plasma membrane to interfere with the ligation between stimuli and its specific receptors in culture keratinocytes (Paller et al., 1993) . In the case of interaction between Ras and GM3, Matyas et al. (1987) reported that an apparent increase of GM3 expression was induced by Ras-transfection into NIH3T3 cells. Although the expression profiling of glycosphingolipid may be different on cell lineage, however, in the present study, deletion of GM3 did influence MAPK signaling initiated by Ras activation without altering the expression of total Ras (Figure 2a ). In addition, the deletion of caveolin-1 is reported to drive the activity of MAPK, whereas the overexpression of caveolin-1 downregulates MAPK in NIH3T3 cells. More interestingly, caveolin-1 mutant cells also made foci (Galbiati et al., 1998) ; a tumorigenic character similar to GM3 KO MEFs as shown in Figure 5 . Although a precise mechanism was not elucidated, these evidences suggested that regulation of membrane-transmitted signaling appeared to implicate crosstalk between glycosphingolipids and other transducer molecules.
In summary, we demonstrated here that GM3 KO MEFs showed unique characteristics in mitogenic signaling, that is, constitutive upregulation of MAPK cascade and resistance for entering cell cycle arrest. The next step will be to examine the interaction between gangliosides and cell surface receptors. Analyses are ongoing to clarify the specific roles of gangliosides in cooperating with various growth stimuli.
Materials and methods
Antibodies and regents
Anti-ERK antibodies, anti-phospho-ERK antibodies, anti-cFos antibodies, anti-Fra-1 antibodies, anti-c-Jun antibodies, anti-Jun-B antibodies and anti-Jun-D antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-cyclin D1/2 antibodies, anti-Ras antibodies and anti-p21 antibodies were from Upstate Biotechnology (Lake Placid, NY, USA). Anti-p27 antibodies were from BD Transduction Laboratories (Lexington, KY, USA). Antiphospho-Raf antibodies, anti-MEK1 antibodies and anti-phospho-MEK1 antibodies were from Cell Signalling Technology (Beverly, MA, USA). Anti-GM3 antibodies were from SEIKAGAKU AMERICA (Falmouth, MA, USA). Ganglioside GM3 was from Alexis Corporation (Norwalk, CT, USA) and PD98059 was from Sigma (St Louis, MO, USA).
Preparation of primary MEFs
MEFs were isolated from 13.5 d.p.c. mouse embryos (Tanaka et al., 1997) . In brief, embryos were separated from maternal tissues and yolk sack, and then minced and incubated in 0.25% trypsin EDTA (Invitrogen, Carlsbad, CA, USA) at 371C for 15 min. The supernatant was centrifuged for 3 min at 2000 r.p.m., and the pellets were resuspended in medium and filtered onto plastic plates for culture. Cells were maintained in Dulbecco's modified Eagle's medium (DMEM; Invitrogen), supplemented with 10% heat-inactivated, fetal bovine serum (FBS; Hyclone, Logan, UT, USA) and 1% antibiotics (penicillin-streptomycin; Invitrogen) in a humidified incubator at 371C in the presence of 5% CO 2 . All animal procedures were approved by the National Institute of Diabetes and Digestive and Kidney Diseases and were performed in accordance with the National Institutes of Health guidelines. In all experiments, cells from passage 3-5 were used.
Gangliosides purification and high performance thin-layer chromatography Total lipid samples of MEFs were prepared by extracting the lyphophilized staring cells with chloroform, methanol (2:1 by volume) for 16 h at room temperature. Sample extracts were mixed with water ( Â 0.2 by volume of extracts) and centrifuged at 2000 r.p.m. for 20 min. Acid gangliosides in the upper aqueous phase and neutral gangliosides in the lower phase were further purified for solid-phase extraction using Sep-Pak cartridge (Waters Corp., Milford, MA, USA), and subjected to the thin-layer chromatography (Li et al., 2000) .
Immunohistochemical staining of GM3
MEFs were incubated on chamber slides and fixed by cold acetone for 10 s. Immunohistochemical staining was performed using avidin-biotin-peroxidase complex (Hashiramoto et al., 1999) . Primary antibodies to GM3 (monoclonal antimouse IgM, 1:100 dilution) were reacted for 24 h at 41C, and FITC-conjugated secondary antibodies (goat anti-mouse IgM, 1:500 dilution, Molecular Probes, Eugene, OR, USA) were reacted for 1 h at room temperature.
Cell proliferation assay
MEFs, placed onto 96-well plates, were cultured for 24 h in medium containing 10% FBS. Cell viabilities were measured as the absorbance (450 nm) of reduced WST-8 [2-(2-methoxy-4-nitrophenyl)-3-(4-nitriphenyl-0-5-(2,4-disulfonyl)-2H-tetrazolium, monosodium salt), using Cell Counting Kit-8 (Dojindo Molecular Technologies, Gaithersburg, MD, USA) (Itano et al., 2002) .
SDS/PAGE and immunoblotting
MEFs were washed twice with PBS and lysed for 30 min on ice with lysis buffer A (25 mM Tris pH 8.0, 1% Nonidet P-40, 150 mM NaCl, 1.5 mM EGTA, 0.5% sodium deoxycholete, 1 mM PMSF, 10 mM sodium orthovanadate and 3 mg/ml aprotinin). Samples were clarified by centrifugation and subjected to SDS/PAGE (Kawahito et al., 2000) . Proteins were transferred to nitrocellulose membrane (Invitrogen) and probed with specific anti-sera. Blots were developed by enhanced chemiluminescence detection system (ECL: Amersham, Arlington Heights, IL, USA). For the detection of GTP-bound activated Ras, MEFs were lysed in buffer B (10 mM MgCl 2 in buffer A). Affinity precipitation was performed with a GST-Ras-binding domain conjugated agarose beads (Upstate Biotechnology), followed by immunobloting with anti-Ras antibody.
Nuclear fractionation
MEFs were washed twice with PBS, resuspended in 2 volumes of ice-cold buffer C (10 mM HEPES pH7.9, 1.5 mM MgCl 2 , 10 mM KCl, 1 mM PMSF and 10 mM sodium orthovanadate), and homogenized by 20 strokes using Dounce homogenizer, as described previously (Dignam et al., 1983) . The nuclear fraction was separated from the remaining cell lysate by centrifugation at 1000 g for 10 min at 41C.
Plasmid and transfections
To construct the pCIneo-Siat9 cDNA-encoding GM3 synthase, the 2.2 kb Siat9 cDNA fragment (Kono et al., 1998) was digested by EcoRI and inserted into the pCIneo plasmid (Promega, Madison, WI, USA). The directions for sense and antisense were confirmed by sequencing. GM3 KO MEFs, grown in DMEM containing 10% FCS, were transfected for 3 h in serum-free DMEM containing up to 2 mg of total plasmid DNA together with the Lipofectamine Plus Reagent (Invitrogen), according to the manufacturer's instruction. . At 24 h after plating, cells were examined under the phase-contrast microscopy, or stained with acid hematoxylin solution (Sigma) after fixed by cold acetone (Gorbacheva et al., 2002) . Numbers of focus was counted in 10 different eyefields under microscopy using hematoxylin-stained samples for quantitation.
Foci-formation assay
DNA-binding activity assay
MEFs, placed onto 12-well plates, were cultured in medium containing 10% FBS with and without PD98059 (10 or 50 mM). Cells were washed twice with PBS, resuspended in 2 volumes of ice-cold buffer C and homogenized on ice. The nuclear fraction was separated from the cell lysate by centrifugation at 1000 g for 10 min at 41C. The binding activity between c-Fos and AP-1 consensus-binding site was detected using TransAMt AP-1/cFos Transcription Factor Assay Kit (ACTIVE MOTIF, Carlsbad, CA, USA). Each of the three different strains of MEFs was tested.
Stastical analyses
Two-tailed independent Student's t-test was used in Figures 1c,  3c , 4a, 5b and 6c.
